Myelin P2 Activators
Myelin P2, a peripheral membrane protein, is prominently associated with the myelin sheath of peripheral nerves. It plays a significant role in the structural integrity and stability of myelin, which is essential for the efficient conduction of electrical impulses along nerve fibers. Myelin P2 facilitates the compaction of the myelin sheath, ensuring rapid signal transmission and protecting nerve fibers from external chemical and physical damage. Beyond its structural role, Myelin P2 is involved in lipid binding, particularly with fatty acids, indicating a role in the transport and regulation of lipids within the myelin sheath. This function is critical for myelin maintenance, repair, and the overall homeostasis of nerve fibers, highlighting the protein's importance in nervous system functionality and integrity.
The activation and function of Myelin P2 are closely tied to its interaction with lipids and the broader cellular environment. Activation mechanisms are primarily governed by its binding affinity to specific lipid molecules, which can induce conformational changes in Myelin P2, affecting its structural and functional roles within the myelin sheath. These interactions are crucial for the protein's ability to participate in the organization and maintenance of the myelin structure. Furthermore, environmental cues such as changes in pH, ionic strength, and the presence of specific fatty acids can modulate Myelin P2's activity, suggesting that its activation is sensitive to the cellular and extracellular milieu. This sensitivity ensures that Myelin P2's activity is finely tuned to the needs of the myelin sheath, facilitating its adaptation to varying conditions and thereby supporting the dynamic processes of myelination, remyelination, and nerve repair. Through these mechanisms, Myelin P2 plays a pivotal role in the maintenance of nervous system health and function, demonstrating the complexity of protein-lipid interactions in cellular physiology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A769662, an AMP-activated protein kinase (AMPK) activator, directly influences Myelin P2 by activating AMPK. This kinase plays a crucial role in cellular energy homeostasis, and its activation by A769662 leads to downstream effects that enhance Myelin P2 expression and function. The activation of AMPK positively modulates the protein, promoting its engagement in myelination processes. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, a diterpene found in the Indian plant Coleus forskohlii, activates adenylate cyclase, leading to increased cAMP levels. Elevated cAMP signaling directly impacts Myelin P2, enhancing its expression and function. The downstream effects of Forskolin on cAMP-mediated pathways contribute to the positive modulation of Myelin P2, emphasizing the role of intracellular signaling cascades in regulating the protein's involvement in myelination. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Rosiglitazone, a thiazolidinedione used in diabetes treatment, activates peroxisome proliferator-activated receptor gamma (PPARγ). This activation indirectly influences Myelin P2 by modulating PPARγ-dependent pathways. The altered transcriptional activity of PPARγ, induced by Rosiglitazone, positively impacts Myelin P2 expression, highlighting the role of nuclear receptors in regulating the protein's involvement in myelination processes. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
GSK-3 Inhibitor IX (BIO) indirectly activates Myelin P2 by inhibiting GSK-3β. This kinase negatively regulates Myelin P2 through phosphorylation, and its inhibition by 6-Bromoindirubin-3'oxime relieves this inhibition, leading to enhanced Myelin P2 activity. The compound's action highlights the significance of kinase-mediated regulation in modulating Myelin P2 function in the context of myelination. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast, a phosphodiesterase (PDE) inhibitor, increases intracellular cGMP levels. Elevated cGMP signaling directly influences Myelin P2 expression and function. By preventing cGMP degradation, Zaprinast positively modulates the protein, emphasizing the role of cyclic nucleotide signaling in regulating Myelin P2's contribution to myelination processes. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR, an AMPK activator, mimics the effects of AMP on AMPK activation. The direct activation of AMPK by AICAR positively impacts Myelin P2 by enhancing its expression and function. This pharmacological activation of AMPK showcases the potential for manipulating cellular energy sensing mechanisms to modulate Myelin P2 activity and contribute to the regulation of myelination processes. | ||||||
GW 0742 | 317318-84-6 | sc-203991 sc-203991A | 10 mg 50 mg | $194.00 $831.00 | 11 | |
GW0742, a selective PPAR-δ agonist, activates PPAR-δ-dependent pathways, indirectly impacting Myelin P2. The altered transcriptional activity induced by GW0742 positively modulates Myelin P2 expression, emphasizing the role of nuclear receptors in regulating the protein's involvement in myelination processes. The compound's specific activation of PPAR-δ provides a targeted approach to enhance Myelin P2 functionality. | ||||||
Icariin | 489-32-7 | sc-279198 sc-279198A sc-279198B | 1 g 5 g 10 g | $145.00 $421.00 $830.00 | ||
Icariin, a flavonoid, activates the PI3K/Akt pathway by promoting Akt phosphorylation. This direct activation positively influences Myelin P2 by enhancing the activity of PI3K/Akt-dependent signaling cascades. The compound's action highlights the significance of growth factor-like signaling in modulating Myelin P2 expression and function, providing insights into the regulatory mechanisms governing the protein's role in myelination. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium orthovanadate, a protein tyrosine phosphatase (PTP) inhibitor, indirectly activates Myelin P2 by inhibiting PTPs. The inhibition of PTPs leads to increased tyrosine phosphorylation events, positively influencing Myelin P2 expression and function. The compound's action emphasizes the role of phosphatase-mediated regulation in modulating Myelin P2 activity and its contribution to myelination processes. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
BML-275 (Compound C), an AMPK inhibitor, indirectly influences Myelin P2 by inhibiting AMPK. This inhibition negatively impacts Myelin P2 expression and function by preventing the normal activation of AMPK-dependent pathways. The compound's action highlights the significance of AMPK-mediated regulation in modulating Myelin P2 activity and its contribution to the regulation of myelination processes. | ||||||